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Purpose: Phenotypic transformation of retinal pigment epithelial (RPE) cells contributes to the onset and progression of
ocular proliferative disorders such as proliferative vitreoretinopathy (PVR). The formation of epiretinal membranes in
PVR may involve an epithelial-mesenchymal transformation (EMT) of RPE cells as part of an aberrant wound healing
response. While the underlying mechanism remains unclear, this likely involves changes in RPE cell gene expression
under the control of specific transcription factors (TFs). Thus, the purpose of the present study was to identify TFs that
may play a role in this process.
Methods: Regulatory regions of genes that are differentially regulated during phenotypic transformation of ARPE-19
cells, a human RPE cell line, were subjected to computational analysis using the promoter analysis and interaction network
toolset  (PAINT).  The  PAINT  analysis  was  used  to  identify  transcription  response  elements  (TREs)  statistically
overrepresented in the promoter and first intron regions of two reciprocally regulated RPE gene clusters, across four
species including the human genome. These TREs were then used to construct transcriptional regulatory network models
of the two RPE gene clusters. The validity of these models was then tested using RT–PCR to detect differential expression
of the corresponding TF mRNAs during RPE differentiation in both undifferentiated and differentiated ARPE-19 and
primary chicken RPE cell cultures.
Results: The computational analysis resulted in the successful identification of specific transcription response elements
(TREs) and their cognate TFs that are candidates for serving as nodes in a transcriptional regulatory network regulating
EMT in RPE cells. The models predicted TFs whose differential expression during RPE EMT was successfully verified
by reverse transcriptase polymerase chain reaction (RT–PCR) analysis, including Oct-1, hepatocyte nuclear factor 1
(HNF-1), similar to mothers against decapentaplegic 3 (SMAD3), transcription factor E (TFE), core binding factor,
erythroid transcription factor-1 (GATA-1), interferon regulatory factor-1 (IRF), natural killer homeobox 3A (NKX3A),
Sterol regulatory element binding protein-1 (SREBP-1), and lymphocyte enhancer factor-1 (LEF-1).
Conclusions:  These  studies  successfully  applied  computational  modeling  and  biochemical  verification  to  identify
biologically relevant transcription factors that are likely to regulate RPE cell phenotype and pathological changes in RPE
in response to diseases or trauma. These TFs may provide potential therapeutic targets for the prevention and treatment
of ocular proliferative disorders such as PVR.
The retinal pigment epithelium (RPE) is a monolayer of
hexagonally  packed,  highly  pigmented,  polarized  cells
located  on  the  posterior  wall  of  the  eye,  whose  apical
membranes are intimately associated with the outer segments
of photoreceptor cells of the neural retina (NR). The RPE
forms the outer blood-retinal barrier and carries out important
physiologic  and  protective  functions  necessary  for  visual
processing in rod and cone cells, such as retinoid metabolism,
phagocytosis  of  discarded  rod  and  cone  outer  segments,
absorption of stray light to preserve visual acuity, control of
water and ion flow between the neural retina and choroid, and
protection of the neural retina from oxidative damage [1–3].
These functions require maintenance of intimate association
of the RPE with the NR, which if disrupted leads to severe
Correspondence to: Gerald B. Grunwald, Department of Pathology,
Anatomy  and  Cell  Biology,  Thomas  Jefferson  University,  1020
Locust Street, Philadelphia, PA, 19107; Phone: (215) 503-4191;
FAX: (215) 503-6690; email: gerald.grunwald@jefferson.edu
ocular pathologies. In situ, the RPE is both non-proliferative
and non-migratory, yet these cells have been shown to exhibit
a high degree of plasticity in vitro. The plasticity in function
and phenotype of the RPE can be recapitulated in vivo when
damage occurs to the retina in the form of a retinal detachment
or  tear.  Therefore  retinal  detachments  and  tears  require
surgical repair of the RPE/NR interaction [4]. However, as
many as 10% of all rhegmatogenous retinal detachments, in
which  a  retinal  tear  occurs,  result  in  failure  due  to  the
occurrence of proliferative vitreoretinopathy (PVR).
PVR  is  characterized  by  the  formation  of  epiretinal
membranes, comprised in part of dedifferentiated RPE cells
that undergo epithelial-mesenchymal transformation (EMT)
and contribute to this fibroplastic response [2,5,6]. While the
cause of PVR remains unknown, one aspect of this disease
includes changes in the expression of a variety of genes that
regulate  RPE  cell  phenotype.  Identification  of  the
transcription factors that maintain RPE cells in a differentiated
non-proliferative  and  non-migratory  state  could  provide
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1414potential therapeutic targets. Studies of EMT in a variety of
cell types in development and disease have begun to identity
such factors [7-9]. More recently, high-throughput technology
such as microarray analysis has identified changes in gene
expression in RPE cells undergoing EMT in vitro, including
genes  involved  in  DNA  synthesis  and  repair,  cell  cycle,
intracellular signaling, and cell adhesion [10,11]. However,
the mechanisms by which these many changes are controlled
during EMT, including the transcriptional regulators that may
coordinate this process, remain to be elucidated.
The  purpose  of  the  present  study  was  to  identify
transcription factors that regulate EMT in RPE cells. Genes
were identified that are upregulated or down-regulated during
RPE EMT, and the genomics tool Promoter Analysis and
Interaction Network Toolset (PAINT v 3.3) [12] was then
used to generate models of the promoter regions of these genes
including  predictions  of  those  TFs  that  regulate  their
expression. We then tested the validity of these models using
RT–PCR to analyze expression of the TFs in differentiated
and undifferentiated RPE cells and indeed identified several
TFs that are differentially expressed between these two RPE
cell  states.  The  results  of  these  studies  indicate  that  a
combination of computational and biochemical approaches
can be successfully applied to analyze these complex events.
METHODS
Computational  analysis  of  gene  regulatory  regions:
Identification and analysis of the regulatory regions of genes
expressed in RPE cells was performed using the Promoter
Analysis  and  Interaction  Network  Toolset  version  3.3
(PAINT)  program  [12].  The  target  gene  set  analyzed
comprised sixty genes differentially expressed during EMT
of RPE cells, selected from previous literature reports and
additional genes under study in our laboratory [10,11] (Table
1). This set was divided into two subsets representing those
preferentially  expressed  in  the  undifferentiated  or
TABLE 1. GENE ONTOLOGY LIST FOR TARGET SEQUENCES USED IN PAINT ANALYSIS
Gene Ontology Gene name Cluster Gene Ontology Gene name Cluster
      Growth factor binding IGFBP-1 Undifferentiated
Cell cycle effectors CDC25A Undifferentiated   IGFBP-3 Undifferentiated
  Cyclin H Undifferentiated   EMAP II Undifferentiated
  Cdc2-related protein kinase Undifferentiated   IL-13 Undifferentiated
  G(1)/G(S)/G(2) beta2 Undifferentiated  
      Cell death Caspase 4 Undifferentiated
Cell adhesion I-CAM-1 Undifferentiated   ICE LAP3 Undifferentiated
  V-CAM-1 Undifferentiated  
  E-selectin Undifferentiated Cell organization alpha-SMA Undifferentiated
  Integrin alpha4 Undifferentiated   ZO1 Differentiated
  Integrin beta5 Undifferentiated   Thymosin beta10 Differentiated
  N-cadherin Undifferentiated  
  Fibronectin Differentiated Signal transduction STK-2 Undifferentiated
  CD44 antigen Differentiated   CAK Undifferentiated
  Integrin alpha5 Differentiated   MAPK3 Undifferentiated
  Integrin beta4 Differentiated   PDGF-B Undifferentiated
  R-cadherin Differentiated   CD33 antigen Undifferentiated
        RGS19IP1 Undifferentiated
Cell metabolism CLK-1 Undifferentiated   FADK2 Undifferentiated
  STK-1 Undifferentiated   Tyk2 Undifferentiated
  Tyrosinase Differentiated   RAB5A Undifferentiated
  PEDF Differentiated   PKCgamma17 Undifferentiated
  RPE65 Differentiated   IGF-1 Undifferentiated
  TYRP2 Differentiated   VEGF Undifferentiated
        MCP-1 Undifferentiated
Ion binding CAM IV Undifferentiated   Neuromodulin Undifferentiated
  SPARC/Osteonectin Differentiated   FADK2 Undifferentiated
        PAK-C alpha Undifferentiated
Transcription factors CRE BP-1 Undifferentiated FGFR-1 Differentiated
  TFAP 2 Undifferentiated FGFR-3 Differentiated
        HDGF Differentiated
Proliferation/differentiation STAT6 Undifferentiated
  GDF-1 Undifferentiated
Inter/intra cellular
transport MAL Undifferentiated
        MCT-4 Undifferentiated
        MCT-3 Differentiated
        Bestrophin Differentiated
The three columns indicate the gene name, gene ontology cluster assignment, and inclusion into either the differentiated or
undifferentiated  retinal pigment epithelium expression cluster. The genes were organized within the ontology clusters according
to The Gene Ontology Consortium (2000).
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1415differentiated state, and further refined by functional gene
ontology [13]. Homologous genes in humans, mice, rats, and
chickens were identified using the Ensembl database and the
Ensembl gene ID for each was used in the PAINT program
[14,15].  For  each  gene,  PAINT  identified  the  putative
transcription  start  site  (TSS)  and  subsequent  promoter
analysis to identify transcription response elements (TREs)
was  performed  to  5,000  bp  upstream  of  the  TSS,  with
exclusion  of  complimentary  strand  analysis  and  1.0  core
similarity  threshold  [12].  In  addition,  sequence  data
corresponding to the first intron of each gene was retrieved
from  Ensembl  and  also  entered  into  PAINT,  as  FASTA
formatted sequences, for further analysis. TREs within both
the promoters as well as first introns were identified using the
MATCH/TRANSFAC  database  [16].  These  TREs  were
entered  into  the  Feasibility  Network  Builder  module  of
PAINT  (FeasNet  Builder),  which  constructed  a  candidate
interaction  matrix  (CIM),  a  graphic  representation  of  the
occurrence of these TREs within the gene set. Enrichment
analysis was performed using PAINT to compute the Fisher's
exact test p-values indicating relative over-representation of
TREs within the selected gene set as compared to the larger
background gene set, the 588 genes present on the Human
Atlas Array (Cat. No. 7740–1; Clontech, Palo Alto, CA) used
to originally identify the set of sixty differentially regulated
RPE genes [10,11]. In each of the analyses, multiple testing
correction was applied using a false discovery rate (FDR)
estimate [17]. In all cases, the multiple testing corrections
were  not  informative  as  they  did  not  result  in  any  over-
represented TREs, since the FDR was consistently above 90%
for all TREs. Therefore, we followed a discovery approach
and chose a threshold of p<0.1 on the Fisher's exact test p-
value to identify those TREs to be included in further filtering
as  described  below.  Models  of  RPE  gene  interaction
networks, based upon results of the FeaseNet analysis, were
graphically generated using GraphViz [18].
Generation  of  models  for  gene  regulatory  regions  and
selection  of  targets  for  biochemical  analysis:  Global
regulatory models for gene sets coordinately expressed in
RPE  cells,  as  well  as  for  individual  genes  differentially
expressed in differentiated or undifferentiated RPE cells, were
developed  based  upon  PAINT-derived  computational  data
and  were  constructed  by  comparing  phylogenetically
conserved transcriptional regulation across the four species:
human,  mouse,  rat,  and  chicken.  To  establish  criteria  for
selection of specific transcription factors for further analysis,
we assigned values to each TRE based upon their frequency
of detection across the coordinately expressed gene sets and
their  evolutionary  conservation.  An  evolutionary
conservation factor (ECF) of 1 to 3 points was assigned to
each  TF,  where  1  indicates  presence  on  human  genes,  2
indicates human and mouse or rat genes, and 3 indicates a
presence on human and chicken as well as either mouse or rat
genes. In addition, TREs were scored according to a frequency
ratio (FR) derived from the ratio of the percent occurrence of
Figure  1.  Candidate  interaction  matrix  for  statistically  enriched
transcription  response  elements  from  promoter  analysis  and
interaction network toolset analysis of human gene promoters. The
retinal pigment epithelium (RPE) gene set was analyzed by promoter
analysis  and  interaction  network  toolset  (PAINT)  and  a  graphic
candidate interaction matrix (CIM) was generated as described in
Methods. The y-axis lists the Ensembl Gene identifiers for each gene
and the x-axis lists the TRANSFAC identifiers for each transcription
response element (TRE) found at least once in the promoter region
of one or more genes. Genes listed along the y-axis are divided into
two clusters that are either upregulated (blue) or down-regulated
(green)  during  epithelial-mesenchymal  transformation  (EMT)  of
RPE cells. TREs listed along the x-axis are clustered according to
related occurrence pattern calculated using Jaccard's coefficient. The
elements within the matrix are color-coded based on the p-value of
each TRE found in the regulatory regions of the genes. A red dot
represents a TRE that is statistically significant and therefore over-
represented in our gene set, while a blue dot signifies an under-
represented TRE and a gray dot stands for a TRE with no statistical
significance in our gene list. This figure represents the subset of
enriched TREs for the human genome; the full CIMs for human and
other genomes analyzed are shown in Appendix 4, Appendix 5,
Appendix 12, and Appendix13.
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1416a given TRE in a specific gene subset divided by its frequency
of occurrence in the background gene set, for the human
genome data. Ultimate TRE selection was based upon criteria
filters of a combined ECF score of 2 or greater along with a
FR greater than 3.
Cell culture: Primary cultures of chick embryo RPE cells
(cRPE) were established from RPE tissues obtained from
fertile  White  Leghorn  chicken  eggs  maintained  in  a
humidified  atmosphere  at  37  °C  until  embryonic  day  10,
corresponding to Hamburger and Hamilton stage 36 [19,20].
Eyes were enucleated, the anterior segment and vitreous were
removed,  and  the  posterior  eyecup  divided  in  half  and
incubated in HBSG (HEPES buffered saline with glucose
containing 1 mg/ml glucose, 10 mM HEPES, pH 7.4, 3 mM
KCl, and 0.15 mM NaCl). The neural retina was removed and
the eyecup was incubated in HBSG containing 20 mM EDTA
Figure  2.  Candidate  interaction  matrix  for  statistically  enriched
transcription  response  elements  from  promoter  analysis  and
interaction network toolset analysis of human gene first introns. The
retinal pigment epithelium (RPE) gene set was analyzed by promoter
analysis  and  interaction  network  toolset  (PAINT)  and  a  graphic
candidate interaction matrix (CIM) was generated as described in
Methods. The y-axis lists the Ensembl Gene identifiers for each gene
and the x-axis lists the TRANSFAC identifiers for each transcription
response element (TRE) found at least once in the first intron region.
Genes listed along the y-axis are divided into two clusters that are
either upregulated (blue) or down-regulated (green) during EMT of
RPE cells. TREs listed along the x-axis are clustered according to
related occurrence pattern calculated using Jaccard's coefficient. The
elements within the matrix are color-coded based on the p-value of
each TRE found in the regulatory regions of the genes. A red dot
represents a TRE that is statistically significant and therefore over-
represented in our gene set, while a blue dot signifies an under-
represented TRE and a gray dot stands for a TRE with no statistical
significance in our gene list. This figure represents the subset of
enriched TREs for the human genome; the full CIMs for human and
other  genomes  analyzed  are  shown  in  Appendix  14  through
Appendix 17.
(ethylene diamine tetraacetic acid) for 1 h. The eye cups were
then rinsed for an additional 30 min in HBSG and the RPE
was dissected from the choroid. RPE tissue was collected by
gentle  centrifugation  and  resuspended  in  MEM  (Eagle's
minimum essential medium; Sigma-Aldrich, St. Louis, MO)
supplemented with 10% FBS (Fetal Bovine Serum; Sigma-
Aldrich),  0.22%  sodium  bicarbonate  and  1%  penicillin,
streptomycin and amphotericin (Gibco/Invitrogen, Carlsbad,
CA). The RPE tissue was mechanically dissociated into single
cells and plated onto plastic six well tissue culture plates at a
density of 1 eye/well. The plates were previously coated with
1.1 μg/cm2 mouse laminin (Sigma-Aldrich) 12 h before cell
plating.  The  cultures  were  maintained  in  a  humidified
atmosphere of 5% CO2 at 37 °C for 48 h at which time all non-
adherent cells were removed by rinsing with fresh medium
[21].
The human RPE-derived cell line ARPE-19 [22] was
maintained cultured in DMEM-F12 (Catalog number D8900;
Dulbecco's modified eagles minimum nutrient mixture F12
Ham; Sigma-Aldrich) supplemented with 5% FBS, 2 mM L-
glutamine, 0.348% sodium bicarbonate and 1% Antibiotic-
Antimycotic in T25 culture flasks in a humidified atmosphere
of 5% CO2. To maintain cells in an undifferentiated state, they
were  passaged  before  obtaining  confluence.  To  obtain
differentiated cells, cells were grown to confluence and then
maintained in DMEM-F12 as above except that the serum was
reduced to 1% [23]. These cultures reach confluence 2–3
weeks after passaging and differentiate within 4–6 weeks,
though the cultures can be kept in a differentiated state for
extended culture periods. After 4–6 weeks in culture the cells
exhibit hexagonal packing of pigmented, polarized epithelia
and  expression  of  CRALBP  and  RPE65  typical  of
morphological and biochemical markers, respectively, of RPE
cells in vivo [22].
RNA extraction and reverse transcriptase polymerase chain
reaction amplification: Total RNA was extracted from all cell
types using the Micro-to-Midi Total RNA Purification System
(Invitrogen,  Carlsbad,  CA)  following  manufacturers
specifications for isolation of RNA from animal tissues. Purity
and concentration of RNA from each sample was assessed on
a spectrophotometer at 260 nm wavelength (A260). All primers
used in this study are listed in Appendix 1 and were designed
using the web-based tool GeneFisher Primer Design program,
and all ranged between 20 and 22 nucleotides in length, with
melting temperatures of 50–65 °C and G-C content between
40%–60% [24]. Primer specificity was determined by the
nucleotide-nucleotide  basic  local  alignment  search  tool
(BLASTn) set to the specific species genome, with acceptance
of a primer pair based upon expect-value of less than 1 (e-
value <1) [25]. RT–PCR was performed using the SuperScript
III One-Step RT–PCR System with Platinum Taq (Invitrogen,
Carlsbad, CA) according to the manufacturer's instructions.
The reaction parameters were (a) cDNA synthesis, 1 cycle at
55 °C for 30 min, (b) denaturation, 1 cycle at 94 °C for 2 min,
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primer-specific temperatures for 30 s, (e) extension, 68 °C for
1 min, and (f) final extension, 1 cycle at 68 °C for 5 min. RT–
PCR products were analyzed by agarose gel electrophoresis
on 1.25% gels containing ethidium bromide (1 μg/ml). The
resultant bands were visualized and recorded under ultraviolet
light using the Kodak 1D photo system.
RESULTS
Transcriptional regulatory network analysis of differentially
expressed retinal pigment epithelium genes reveals gene set-
specific  clusters  of  transcription  response  elements:  To
identify target genes for the analysis of transcription response
elements  by  PAINT,  a  gene  set  containing  two  clusters
representing those genes whose expression is preferentially
associated with the undifferentiated versus differentiated state
of the ARPE-19 cells was established (Table 1). Thus each
gene cluster would be predicted to be preferentially associated
with one or more TREs involved in their respective coordinate
regulation of expression. The genes within the differentiated
and undifferentiated clusters were separately analyzed using
PAINT to identify and statistically analyze the occurrence of
TREs  within  the  promoter  region,  including  5,000  bp  of
sequence upstream from the transcription start site, as well as
the entire first intron sequence. The complete results of this
analysis by the FeasNet Builder module of PAINT are listed
in Appendix 2 for the promoter regions and Appendix 3 for
the first introns. The analysis identified those TREs that are
statistically  over-represented  on  the  promoters  and  first
introns of genes within either of the two gene clusters, as
compared to their occurrence with the larger background set
of promoter and intron regions. TREs with a p-value of less
than 0.1 were deemed significant and included for further
analysis.  These  data  were  then  converted  into  graphic
representations of the TRE network or CIM, using the FeasNet
Viewer module of PAINT, as illustrated in Figure 1 for the
promoter  regions  and  in  Figure  2  for  the  first  introns.
Inspection  of  the  matrix  patterns  for  the  respective
differentiated and undifferentiated gene clusters indicated that
distinct subsets of TREs were associated with each of these
two  clusters,  suggesting  that  these  TREs  could  represent
components  of  the  networks  regulating  coordinated
expression of genes within each cluster. Figure 1 and Figure
2 represent a subset of the complete CIM, and include only
those TREs with a p-value of less than 0.1. The complete
CIMs representing the results of the analysis of the full 60
gene set are tabulated in Appendix 2 and Appendix 3, as well
as illustrated in Appendix 4 and Appendix 5. The results of
the  CIM  analysis  indicate  that  several  specific  TREs  are
statistically overrepresented within the regulatory regions of
genes within each gene subset, and furthermore that several
of these TREs differ between the two subsets. These distinctly
represented  TREs  are  thus  candidates  for  further  analysis
regarding their potential regulatory role in coordinating gene
expression during RPE cell differentiation.
To further visualize the potential interrelationships of the
candidate  TREs  and  genes  within  each  cluster,  the  data
generated by the FeasNet Viewer module was graphically
presented using GraphViz to generate a regulatory network
diagram for the human gene set, as illustrated in Figure 3 for
the promoter regions and Figure 4 for the first introns. These
results identify nodes within each network and further identify
those TREs with the potential to coordinately regulate subsets
of genes within each cluster. The TREs that comprise the
nodes of this visualization represent all those TREs which are
overrepresented among the genes of each cluster, and were
found to be associated with as few as one gene within each
cluster to as many as 28 genes within a cluster. Those TREs
exhibiting high levels of interconnectivity are among the best
candidates for coordinate regulation of RPE genes.
To identify those TREs of particular significance in the
differential regulation of RPE genes during EMT, we next
performed  an  analysis  comparing  all  the  overrepresented
TREs from the CIM analysis with respect to their relative
frequency  of  occurrence  between  the  differentiated,
undifferentiated  and  background  gene  clusters.  While  the
previous analyses identified TREs overrepresented in either
or both of the two gene clusters, the frequency analysis further
distinguished those TREs preferentially associated with either
Figure  3.  Transcriptional  regulatory  network  diagram  for
transcription  response  element  associated  with  human  promoter
regions. The graphical representation was derived using GraphViz
as  described  in  Methods.  The  ellipses  and  diamonds  represent
individual genes divided into upregulated (blue) and down-regulated
(green) clusters. The boxes represent TREs, with arrows indicating
gene-TRE  associations.  Corresponding  network  diagrams  for
mouse, rat and chick promoter regions are shown in Appendix 18
through Appendix 20.
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1418the differentiated or undifferentiated gene cluster. The results,
which are shown in Figure 5 for the promoter regions and
Figure 6 for the intron regions, indicate that a select subgroup
of the TREs can be assigned as potential regulators of one of
each of the two cell states. For example, in the promoter
regions,  Hand1:E47  and  COMP1  show  increased  relative
frequency among down-regulated genes, whereas Oct-1 and
SREBP-1 do so among upregulated genes. In the first intron
regions,  CDP  and  IRF  show  increased  relative  frequency
among down-regulated genes, whereas GATA-3 and MAZR
do so among upregulated genes.
Phylogenetic  comparison  of  PAINT  analyses  identifies
evolutionarily conserved transcriptional regulatory elements
across  divergent  species:  The  above  studies  of  gene
regulatory networks regulating RPE cell differentiation were
focused  on  human  genome  sequence  analysis.  However,
evolutionary conservation analysis of regulatory regions can
also be useful for identifying functionally important sites.
Therefore,  to  further  identify  those  elements  of  these
hypothetical networks that would most likely be of functional
significance  due  to  their  evolutionary  conservation,  we
performed parallel PAINT analyses similar to those described
above for human genomic elements for three additional model
species: mouse (Mus musculus), rat (Rattus norvegicus), and
chicken (Gallus gallus). The results of the FeasNet Builder
analysis in the three additional species gene sets indicate that,
as  observed  for  the  analysis  of  human  genes,  several
overrepresented  TREs  are  again  identified  (Appendix  6,
Appendix 8, and Appendix 10 for the promoter regions and in
Appendix  7,  Appendix  9,  and  Appendix  11  for  the  first
Figure  4.  Transcriptional  regulatory  network  diagram  for
transcription response element associated with human first intron
regions. The graphical representation was derived using GraphViz
as  described  in  Methods.  The  ellipses  and  diamonds  represent
individual genes divided into upregulated (blue) and down-regulated
(green) clusters. The boxes represent TREs, with arrows indicating
gene-TRE  associations.  Corresponding  network  diagrams  for
mouse, rat and chick first intron regions are shown in Appendix 21
through Appendix 23.
introns) for each species. The graphical candidate interaction
matrix for each of these three species is shown in Appendix
12, Appendix 13, Appendix 14, Appendix 15, Appendix 16,
and Appendix 17, while the GraphViz output of the FeasNet
Viewer analyses illustrating the regulatory network diagrams
for these three species is shown in Appendix 18, Appendix
19, Appendix 20, Appendix 21, Appendix 22, and Appendix
23,  which  both  again  indicate  the  presence  of  a  complex
regulatory network within each of these species. As for the
human  genome,  we  also  compared  the  frequency  of
occurrence of each identified TRE between each gene cluster
and the background gene set for each of the three model
species. These frequency analyses are shown in Appendix
24, Appendix 25, Appendix 26, Appendix 27, Appendix 28,
and  Appendix  29.  As  for  the  human  genome  analysis
discussed above, these results of the CIM, GraphViz and
frequency analyses identify TREs for each of the three species
which are also candidates for regulation of gene expression
during RPE differentiation. Comparison of the results from
the human as well as model system analyses identified both
phylogenetically conserved as well as species-specific TREs,
which  were  incorporated  into  criteria  tables  and  gene
regulatory region models as described below (Table 2 and
Figure 7).
Compilation  of  human  and  cross-species  transcriptional
regulatory network analyses generates global as well as gene-
specific regulatory models: To generate a global working
Figure  5.  Frequency  analysis  of  transcription  response  element
representation in human promoter regions. Frequency of occurrence
of each transcription response element (TRE) in the human gene
promoter regions was determined from the promoter analysis and
interaction  network  toolset  (PAINT)  analysis  as  described  in
Methods. The y-axis indicates the frequency of each TRE among the
upregulated (blue) or down-regulated (green) gene clusters as well
as among the full background gene set (black). The x-axis indicates
the  over-represented  TREs,  ordered  by  increasing  p-value.
Corresponding frequency analyses for mouse, rat and chick promoter
regions are shown in Appendix 24 through Appendix 26.
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1419model of gene expression regulation in the RPE, we compared
the  above  results  across  the  four  species  analyzed  and
identified those TREs of highest evolutionary conservation,
as well as highest frequency of occurrence, by calculation of
an evolutionary conservation factor (ECF) score, as well as a
frequency ratio (FR) score, for each TRE identified in the
computational analysis, as described in Methods. The results
of these calculations are shown in Table 2, with the table
containing only those results for TREs that passed the three
criteria of a p-value >0.1, an ECF greater or equal to 2, and an
FR greater or equal to 3. The full data set of calculated ECFs
and FRs for all the TREs identified in the computational
analysis is shown in Appendix 30, for the promoter regions
and  Appendix  31  for  the  first  intron  regions.  These
calculations  provide  a  scheme  for  ranking  TREs,  and  by
extension their corresponding TFs, for inclusion into models
of RPE gene regulation, as well as for further studies probing
their expression and function in RPE differentiation.
The  TREs  passing  all  these  criteria,  and  hence
representing potentially evolutionarily conserved regulators
of RPE gene expression, were incorporated into archetypal
gene models for the coordinated up- and down-regulation of
genes during RPE cell differentiation, as shown in Figure 7.
Although evolutionary conservation is a potential indicator of
conserved  function,  in  recognition  of  the  likelihood  that
species-specific aspects to coordinated gene regulation also
exist, we also developed an additional model with modified
ECF criteria focused on regulation in the human genome, such
that  incorporation  of  TREs  into  this  second  model  was
dependent on the TRE occurring within the human gene set
and any one additional species, while maintaining the same p-
value and FR criteria filters. The resulting models are shown
in Figure 8, and share many elements of the trans-species
model,  in  some  cases  eliminating  TREs  not  found  in  the
human analysis, while adding some others due to the less
stringent  ECF  criteria.  Finally,  additional  gene-specific
regulation  models  were  constructed  for  selected  genes
representing paired members of multigene families, or other
markers,  with  reciprocal  expression  during  RPE  cell
differentiation. These paired models were constructed for the
cell  adhesion  proteins  N-  and  R-cadherin,  for  the  lactate
transporters MCT3 and −4, and for α-smooth muscle actin and
RPE65 (Figure 9). These gene regulation models identify
those TREs most likely to coordinate expression of specific
genes as well as broader sets of up- and down-regulated genes
during  RPE  cell  differentiation,  and  provided  targets  for
validation  of  these  models  through  direct  biochemical
analysis as described below [22,23,26].
Validation of gene models by identification of transcription
factors whose expression is dependent upon the state of retinal
pigment  epithelium  cell  differentiation:  The  above  gene
regulatory  models  identified  TREs  that  could  serve  as
elements of the gene regulatory network during RPE cell
differentiation. For these TREs to play a role in regulation of
their  associated  genes,  the  activity  of  the  corresponding
transcription factors would be expected to be dynamically
regulated at appropriate times to effect such control. One
common mechanism of regulation for TF activity is at the





E2F-1/V$E2F1_Q3_01 0.00095 2 3.725
Oct-1/V$OCT1_02 0.00801 3 4.25
Nkx2–5/V$NKX25_02 0.05404 2 2.3
Poly A/V$LDSPOLYA_B 0.07291 2 2.16
IRF/V$IRF_Q6_01 0.08969 2 2.33
COMP1/V$COMP1_01 0.03569 2 2.52
First intron
Evi-1/V$EVI1_05 0.00003 2 13.86
Oct-1/V$OCT1_02 0.00043 2 6.32
GR/V$GRE_C 0.00045 2 14.6
SMAD-3/V$SMAD3_Q6 0.00071 3 3.18
HNF-1/V$HNF1_01 0.00918 2 7.35
AP-1/V$AP1_C 0.01893 2 4.87
Represented for each transcription response elements (TRE) identified in the promoter and intron regions of each gene are the
TRANSFAC  identifier name, the p-value, the evolutionary conservation factor (ECF), and the frequency ratio (FR) as defined
in Methods. TREs included in this table are those with p-value <0.1, ECF=2, and FR>3. The full table of values for all TREs
analyzed is contained in Appendix 30  (promoters) and Appendix 31 (introns).
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1420transcriptional  level  resulting  in  differential  steady-state
mRNA expression levels. Thus, to test the computationally
derived models, we used RT–PCR to assay for the presence
of mRNA encoding transcription factors (TFs) predicted to
play a regulatory role in the RPE. The results obtained from
comparison of mRNA extracted from undifferentiated and
differentiated RPE cells, using both the human ARPE-19 cell
line and primary embryonic chicken RPE cells, are shown in
Figure 10, Figure 11, Figure 12. The analyses of ARPE-19
cells were performed using both undifferentiated cells that
been  in  culture  for  one  month,  exhibiting  morphology  of
fusiform,  unpigmented  mesenchymal  cells,  as  well  as
differentiated  ARPE-19  cells  exhibiting  morphology  of
Figure  6.  Frequency  analysis  of  transcription  response  element
representation in human first intron regions. Frequency of occurrence
of each transcription response element (TRE) in the human gene first
intron regions was determined from the PAINT analysis as described
in Methods. The y-axis indicates the frequency of each TRE among
the upregulated (blue) or down-regulated (green) gene clusters as
well as among the full background gene set (black). The x-axis
indicates the over-represented TREs, ordered by increasing p-value.
Corresponding frequency analyses for mouse, rat and chick first
intron regions are shown in Appendix 27 through Appendix 29.
polygonal, darkly pigmented, epithelial cells (Figure 10A,B).
RT–PCR  was  first  performed  on  each  respective  cell
population  targeting  mRNAs  for  α-SMA  and  RPE65,
respective markers of the mesenchymal undifferentiated and
epithelial differentiated state of RPE cells [22]. These results
indeed demonstrated that mRNA encoding α-SMA, but not
RPE65,  was  expressed  in  undifferentiated  cells,  whereas
RPE65  mRNA  was  readily  detected  among  differentiated
cells with a reduced level of α-SMA mRNA (Figure 10C,D).
Semi-quantitative RT–PCR was used to further distinguish
these  levels  of  α-SMA  mRNA,  which  more  clearly
distinguished  these  two  cell  states  (Figure  10E).  Having
verified  that  these  two  markers  were  distinctly  expressed
between these two cell populations, we then used RT–PCR to
determine  the  levels  of  mRNA  encoding  the  specific
transcription  factors  previously  identified  by  the
computational analysis, which were expected to fall into three
categories, exhibiting either quantitative, qualitative, or no
differences between the two test cell populations. Of these
TFs, mRNAs encoding four were found to be reciprocally
expressed in differentiated versus undifferentiated ARPE-19
cells, with Oct-1 and TFE3 detected only in differentiated
cells, and Core Binding Factor and NKX3A detected only in
undifferentiated  cells  (Figure  11).  mRNAs  encoding
additional transcription factors, including GATA-1, IRF-1,
and SMAD3, were detected in both cell states (Figure 11A).
Semi-quantitative RT–PCR was then used to further analyze
differences in the expression patterns of these factors, with
GATA-1  detected  at  higher  levels  in  differentiated  cells,
whereas IRF-1 and SMAD3 were detected at higher levels in
undifferentiated cells (Figure 11B).
Similar analyses were performed using freshly isolated
chicken RPE tissues and primary chick RPE cultures. When
cultured,  chick  RPE  cells  re-enter  the  cell  cycle  and  de-
differentiate [27]. RNA was prepared from freshly isolated
RPE cells as well as from cells cultured for five days in vitro,
and both cell populations were probed for TFs corresponding
Figure 7. Archetypal cross-species gene regulatory region models of
undifferentiated  and  differentiated  gene  clusters.  These  models
incorporate transcription response element (TREs) that were found
to be over-represented in results of both the human and chicken, as
well as either the mouse or rat, promoter analysis and interaction
network toolset (PAINT) analysis. TSS represents transcriptional
start site.
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1421to those TREs identified in association with both the global as
well as gene-specific regulatory models. The results indicated
that,  similar  to  ARPE19  cells,  and  consistent  with  model
predictions,  the  primary  chick  RPE  cells  also  revealed
reciprocal  TF  expression  between  differentiated  and
undifferentiated cells. mRNAs encoding AML-1 and HNF-1
were detected only in the differentiated chicken RPE cells,
whereas  mRNAs  encoding  HNF-3  and  SREBP-1  were
detected  only  in  the  undifferentiated  cells,  while  two
additional  mRNAs  encoding  TFs  DP-1  and  TFII-I  were
detected in both cell populations (Figure 12). Finally, as an
adjunct to the PAINT-derived analyses, an additional series
of RT–PCR reactions were performed to determine whether
other TFs, not identified through PAINT, but known from
prior studies to be involved in EMT of epithelial cells other
than RPE, were expressed in chick or ARPE-19 cells. As
shown in Figure 13, RT–PCR amplification of mRNA from
undifferentiated and differentiated primary chick RPE cells
generated similar levels of amplicons for Slug, Twist and
SIP1,  whereas  Snail  was  detected  at  higher  levels  in
undifferentiated  cells,  and  LEF1  was  detected  only  in
differentiated cells. When similar analyses were performed
with  total  RNA  isolated  from  differentiated  or
undifferentiated ARPE-19 cells, Slug, Snail, Twist, and SIP1
were not detected, while SMAD2 was detected at equal levels
in both samples. Interestingly, while LEF-1 was also detected
in both cell populations, a distinct additional amplicon was
detected  in  differentiated  RPE  cells,  indicating  that
differential splicing of this gene transcript occurs during the
course  of  RPE  differentiation.  Our  inability  to  detect
expression of certain classical mediators of EMT such as
Snail, Slug, Twist or SIP1 in ARPE-19 cells, while we were
able to detect them in primary cultures of embryonic chick
RPE  cells,  may  be  related  to  the  different  stages  of
Figure 8. Human gene regulatory region models of undifferentiated
and  differentiated  gene  clusters.  These  models  incorporate
transcription response elements (TREs) that were found to be over-
represented in results of the human, and either the chicken, mouse or
rat,  promoter  analysis  and  interaction  network  toolset  (PAINT)
analysis. TSS represents transcriptional start site.
development  represented  by  these  two  model  systems
(embryonic versus adult), to the unique properties of RPE
cells compared to other epithelial cell types that may exhibit
species-specific differences, or to some specific phenotypic
property of ARPE-19 cells that arose during their derivation
[28,29]. Overall, the results of the RT–PCR analyses indicate
that the computational biology approach was successful at
identifying transcription factors whose expression is regulated
during RPE cell differentiation, and thus may play a role in
control of differential gene expression and modulation of RPE
cell phenotype.
DISCUSSION
The  results  of  the  present  study  have  permitted  the
construction of several hypothetical models for regulation of
genes  in  RPE  cells  during  EMT,  each  generated  using  a
different set of theoretical boundaries and statistical criteria.
While the computational approach using the PAINT toolset
has been previously applied to other cell types [12,30], to the
best of our knowledge the present work represents the first
Figure 9. Gene regulatory region models for specific reciprocally-
regulated gene pairs. Models for the paired genes that are reciprocally
regulated during EMT of RPE cells models including N- and R-
cadherin (A), α-SMA and RPE-65 (B), and MCT-3 and −4 (C).
Models were constructed by including only those TREs that are over-
represented in both the human and chicken, as well as either the
mouse or rat, PAINT analysis.
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1422application  to  the  analysis  of  RPE  cell  differentiation.  A
strength of the models developed here is that they make strong
predictions  of  which  TFs  would  be  expected  to  be
differentially acting during phenotypic changes in RPE cells,
predictions  which  were  successfully  tested  and  positively
borne out by the RT–PCR analyses in the present studies.
These results form the basis for design of future studies that
will be directed at testing the function of these various TFs in
regulating RPE cell phenotype. These experiments are guided
by  the  integration  of  the  experimental  results  into  a
comprehensive model for RPE gene regulation (Figure 14),
which indicates for each TRE included in the final model, the
various  criteria  filters  that  led  to  its  inclusion,  including
evolutionary conservation, frequency of occurrence, position
in a gene regulatory network node, and generation of a positive
amplicon in RT–PCR validation assays. Two TFs, Oct1 and
HNF1,  although  not  previously  identified  with  respect  to
EMT, pass all of these four criteria, may play a unique role in
this context in RPE cells, and thus are identified as excellent
candidates for direct functional analysis in future studies.
While not previously analyzed in the context of RPE
cells, the transcription factors identified in the present study
by the PAINT and RT–PCR analyses can be categorized with
Figure 10. Reverse transcriptase polymerase chain reaction analysis
of markers during retinal pigment epithelium cell differentiation.
mRNA was isolated from undifferentiated (A) or differentiated (B)
ARPE-19 cells and subjected to reverse transcriptase polymerase
chain reaction amplification to detect SMA (C) or RPE65 (D) as
described  in  Methods.  Phase-contrast  micrographs  represent
undifferentiated (A) or differentiated (B) ARPE-19 cells after one
week (A) or 52 weeks (B) of culture. C and D represent RT–PCR
amplification  of  mRNA  samples  isolated  from  ARPE-19  cells
maintained in culture for 1, 2, 5, 7, 10, 12, and 52 weeks, using
primers to detect mRNA for either αSMA (C) or RPE65 (D). E
represents RT–PCR amplification for a series of 25, 30, or 35 cycles
to detect αSMA using mRNA isolated from ARPE-19 cells that are
undifferentiated  (U)  differentiated  (D).  The  first  lane  in  C-E
represents a DNA standard ladder of 300, 400, and 500 bp.
respect to other cell types into three groups that include (1)
TFs not previously associated with EMT; (2) TFs that, while
not  previously  known  to  directly  affect  EMT,  have  been
shown to regulate cellular processes that are components of
EMT, and (3) TFs previously shown to directly affect EMT
principally in other cell types. The first group includes the TF
GATA-1, which of all the TFs identified in this study is the
only one not directly linked to an EMT-related process. This
factor is expressed in cells of the erythroid lineage and is
essential for proper erythroid development, but its potential
role in regulation of epithelial cell phenotype remains to be
determined  [30-32].  The  second  group  encompasses  the
factors such as Oct-1, HNF-1, NKX3A, IRF-1, SREBP-1, and
Core Binding Factor, which have not been specifically linked
to EMT, yet regulate processes such as cell migration, cell
adhesion and metabolic pathways associated with EMT. Oct-1
and  HNF-1  act  as  important  regulators  of  development
processes such as neural tube development [33-36]. NKX3A,
a homolog of NKX2–5 that functions to activate N-cadherin
expression in cardiac development, may function in a similar
manner by activating N-cadherin expression, which has been
shown  to  be  highly  expressed  in  metastatic  cancer  cells
[37-41]  and  is  upregulated  during  RPE  de-differentiation.
Figure  11.  Reverse  transcriptase  polymerase  chain  reaction
amplification  of  transcription  response  element  mRNAs  during
ARPE-19 retinal pigment epithelium cell differentiation RNA was
isolated from undifferentiated and differentiated ARPE-19 cells and
subjected to RT–PCR analysis to detected transcription response
element (TRE) mRNAs as described in Methods. In A, all reactions
were  performed  for  40  cycles,  where  lane  1  represents  DNA
standards,  lane  15  represents  the  positive  control  primers  for
GADPH, and lane 16 is the negative control with no mRNA template.
The  intervening  lanes  in  A  represent  primers  specific  for  the
following TFs: 2 Core binding factor, 3 E2F1, 4 Evi-1, 5 GATA1, 6
HNF-1, 7 IRF-1, 8 Nkx2–5, 9 NKX3A, 10 Oct-1, 11 SMAD3, 12
SREBP-1, 13 TFE3, 14 v-Myb. In B, semi-quantitative RT–PCR was
also done for either 30, 35, or 40 cycles as indicated using primers
specific  for  GATA-1,  IRF-1,  or  SMAD3.  The  first  lane  in  A
represents a standard DNA ladder at 300, 400, and 500 bp, while in
B the DNA standards are at 400 and 500 bp.
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falls into this category, in that it plays an important tumor
suppressive role in a wide variety of human neoplasias [42,
43]. Sterol regulatory element binding protein-1 (SREBP-1)
is known to affect expression of lipogenic genes in the liver,
which is of interest insofar as cells undergoing EMTs possess
altered  fatty  acid  and  glucose/insulin  metabolism  [44].
Previous work has shown a switch to aerobic glycolysis when
cells begin to migrate in the initial stages of EMT, an action
Figure  12.  Reverse  transcriptase  polymerase  chain  reaction
amplification  of  transcription  response  elements  mRNAs  during
chick embryo retinal pigment epithelium cell differentiation RNA
was isolated from undifferentiated cultured chick embryo retinal
pigment epithelium (RPE) cells or differentiated fresh RPE tissue
and subjected to RT–PCR analysis to detect transcription response
elements (TREs) mRNAs as described in Methods. Lanes 1 and 11
represent DNA standard ladders at 300, 400, 500, 600, and 700 bp,
lane  10  represents  the  positive  control  for  GADPH,  and  the
remaining lanes represent primers specific for the following TFs: 2
FoxD3, 3 AML-1, 4 HNF-3α, 5 HNF-1, 6 E2F1, 7 DP1, 8 TFII-I, 9
SREBP-1.
Figure  13.  Reverse  transcriptase  polymerase  chain  reaction
amplification of EMT-associated transcription response elements
mRNAs  during  ARPE-19  and  chick  embryo  retinal  pigment
epithelium  cell  differentiation  RNA  was  isolated  from
undifferentiated and differentiated ARPE-19 or chick embryo retinal
pigment epithelium (cRPE) cells and subjected to RT–PCR analysis
to detect transcription response elements (TRE) mRNAs as described
in Methods. Lanes 1 and 16 represent DNA standard ladders at 300,
400, and 500 bp, lanes 8 and 15 represent the positive controls for
GADPH, and the remaining lanes represent primers specific for the
following TFs: 2 and 9, Slug; 3 and 10, Snail; 4 and 11, Twist; 5 and
12, SIP-1; 6 and 13, SMAD-2; 7 and 14, LEF-1.
that may be mediated by SREBP-1 [45]. Core binding factor
(CBF) may also be indirectly involved in EMT, in that it
interacts  with  members  of  the  TGF-β  signaling  factor  to
influence  cell  growth  and  differentiation  [46].  Finally,
SMAD3  and  TFE3  constitute  the  last  group  and  have
previously been strongly implicated in the signaling pathways
associated with TGF-β induced EMT, whereby they activate
LEF-1 transcription, a major EMT inducer [47-51]. These two
TFs are thus also identified as excellent candidates for further
analysis in RPE cells, since they were identified through the
PAINT analysis and have also been previously identified as
regulators of genes associated with EMT in several cell types
[52-56], and in one report in RPE cells [57]. Thus, while this
study has identified several novel potential regulators of the
RPE, the concordance between certain results of the present
study  and  prior  reports  provides  further  validation  of  a
combined in silico computational approach as an adjunct to in
vivo as well as in vitro biochemical and cell biologic studies.
One  potential  limitation  of  the  present  approach  is
indicated by the apparent lack of identification by the PAINT
analysis of some TFs that have been previously associated
with EMT in other cell types and that may play a role in RPE
as well. These include additional downstream mediators of
TGF-β signaling pathways besides SMAD3 such as Snail,
Slug,  Twist,  SMAD2,  SIP1,  β-catenin,  and  LEF-1  [55,
57-61]. As one approach to addressing this, we performed
RT–PCR  assays  to  determine  the  presence  of  mRNAs
corresponding to these TFs, and did detect several of these in
RPE  cells,  although  only  LEF-1  was  indicated  to  be
differentially  expressed  between  differentiated  and
undifferentiated cells. Interestingly, differential splicing of
LEF-1 mRNA, as detected here, has been reported previously
to  generate  several  isoforms  that  may  confer  distinct
Figure  14.  Comprehensive  cross-species  models  for  reciprocal
regulation  of  genes  during  retinal  pigment  epithelium  cell
differentiation Models for regulatory regions, including promoters
and first introns, of differentiated and undifferentiated gene clusters,
were constructed as described in the text. transcription response
elements (TREs) inclusion criteria indicated in these models are
frequency  ratio,  evolutionary  conservation  factor,  and  RT–PCR
detection  of  mRNA  expression.  Symbols  representing  TREs
indicates passage of corresponding criteria filter, as indicated in key,
by TRE, filled boxes signify that a TRE has passed all criteria filters.
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PCR flank the third through sixth exons, the third of which
encodes a premature stop codon that can generate a form of
LEF-1 retaining its β-catenin binding site but lacking DNA
binding domain and nuclear localization signal [62]. Given
the key role of LEF-1 in the TGFβ signaling pathway, this may
indicate one possible means through which modulation of
such pathways occurs during RPE differentiation. For any
TRE  to  be  analyzed  via  PAINT,  its  sequences  must  be
available in TRANSFAC database, and our manual inspection
of this database revealed that no sequences are available for
TREs corresponding to Slug in any species, and Snail, Twist
and SIP1 sequences are available only for the mouse genome,
whereas only SMAD-2 and LEF-1 sequences are available for
all species analyzed in this study. Of these TREs for which at
least partial sequence data was available, although some were
indeed detected by PAINT in some genes within the clusters,
only LEF-1 was enriched with a p-value <0.1, but had a low
ECF value.
A second limitation of the present study is the inherent
variability  observed  in  the  phenotype  of  ARPE-19  cells.
Several  reports  have  indicated  that  there  is  a  degree  of
variability, depending on the culture conditions such as serum
concentration and growth substrate, as well as differences
between  ARPE-19  cells  and  native  human  RPE  [63,64].
While we acknowledge that this inherent variability exists, the
ARPE-19  cells  used  in  the  present  study  were  from
undifferentiated  and  well  differentiated  cell  cultures,
respectively, as defined by both morphological as well as
biochemical criteria.
In situ, the RPE is a monolayer of morphologically and
functionally polarized non-proliferative and non-migratory
cells  whose  unique  properties  are  essential  to  the  proper
development and function of the retina. However, these cells
are known to exhibit a high degree of plasticity in phenotype
and function both in vitro and in vivo [1,3]. Delineating the
mechanisms  underlying  this  plasticity  is  essential  to
understanding the conditions under which RPE cells undergo
these changes, and is critical to developing preventive and
therapeutic  interventions  for  conditions  in  which  RPE
plasticity may lead to retinal diseases such as proliferative
vitreoretinopathy (PVR) [6]. Current therapeutic techniques
used to treat retinal detachments and their complications are
limited to invasive surgical procedures aimed at physically re-
attaching the sensory portion of the retina to the underlying
RPE, and removing epiretinal membranes, such as laser- or
cryo-therapy, supplemented by pneumatic retinopexy, scleral
buckling  or  vitrectomy.  Presently,  PVR  occurs  as  a
complication in up to 10% of surgical retinal detachment
repairs,  making  it  the  most  common  post-surgical
complication  associated  with  these  procedures  [4].
Development of non-surgical or adjunct treatments for PVR
will require a better understanding of the underlying biology
of the genetic and epigenetic mechanisms regulating RPE cell
phenotype and underlying the plasticity exhibited by RPE
cells.  Since  this  plasticity  likely  reflects  changes  in  the
expression  of  a  wide  variety  of  gene  products,  and  thus
ultimately the coordinated function of several transcription
factors, the present study was designed to apply the tools of
computational biology to identify transcription factors whose
function could modulate changes in RPE cell phenotype. The
TFs identified in this study thus become excellent candidates
for further analysis of their role in this process.
In  conclusion,  we  have  predicted  and  experimentally
verified the differential expression of several transcription
factors including Oct-1, HNF-1, SMAD3, TFE, Core binding
factor, GATA-1, IRF, NKX3A, SREBP-1, and LEF-1 that
may be of importance in the regulation of genes during EMT
of RPE cells, as determined first by computational analysis
and modeling, and then tested by direct RT–PCR analysis. The
results  clearly  indicate  that  several  of  these  TFs  are
differentially regulated during RPE differentiation and thus
may play a role in epithelial-mesenchymal transformations of
RPE cells in both developmental and disease processes. These
TFs are thus excellent targets for further studies directed at
testing their role as regulators of RPE cell phenotype, and
consequently may also provide future targets for therapeutic
interventions in cases of PVR and other related disorders of
the eye.
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